Infosys Creating Talent in 'Hidden Jewel'

Posted: Updated:
Infosys President Ravi Kumar Infosys President Ravi Kumar
INDIANAPOLIS -

As India-based Infosys (NYSE: INFY) looks to fill thousands of openings at its tech and innovation hub in Indianapolis over the next few years, the company's president says the onus is on the tech giant to create its own talent. During a Studio(i) interview, Ravi Kumar said it's "myopic if you actually look at just the market and say 'this is the talent pool available.'" He says the company is able to hire people, even without traditional tech skills, thanks to in-house "interventions" consisting of eight-to-twelve weeks of training.

Infosys Tuesday officially opened its location at OneAmerica Tower in downtown Indianapolis. Kumar says it currently houses about 150 employees, with 25 percent of them being local hires. He adds, now that the hub is officially open, that percentage should go up. In all, Infosys plans to hire a total of 2,000 workers by 2021.

The Indy operation focuses on training employees in the technologies and platforms needed to help businesses accelerate digital transformations. The company will also use the hub as an innovation lab to work on prototypes in robotic, virtual and augmented technologies.

Infosys originally announced the $9 million investment in May. In August, the company announced a five-year strategic alliance with Purdue University involving training for the company's American employees, joint research projects and a physical presence for Infosys on campus.

  • Perspectives

    • The Evolution of Business: From Bottom Line to Value Creation And Impact

      In today's world, consumers want to know how corporations, as a whole, are taking a stand. In fact, customers are 43 percent more likely to purchase a product from a company they know is committed to social value. It's not just consumers pushing this trend. Financial service industry leaders, like KeyBank's Beth Mooney and BlackRock's Larry Fink, are challenging business owners and the C-Suite to rethink their economic impact, environmental footprint and social conscience.

    More

Subscribe

Name:
Company Name:
Email:
Confirm Email:
HTML
INside Edge
Morning Briefing
BigWigs & New Gigs
Life Sciences Indiana
Indiana Connections
INPower
Subscribe
Unsubscribe

Events



  • Most Popular Stories

    • St. Vincent Announces Layoffs

      St. Vincent Health says it has laid off 85 employees throughout the state. In a statement to Inside INdiana Business, St. Vincent cites a rapidly-evolving healthcare environment as a reason for the workforce reduction. 

    • GM recently announced it would invest more than $1 billion in its Fort Wayne Assembly plant.

      Auto Job Fair Coming to Allen County

      General Motors is hiring more than 100 new employees in Fort Wayne. The positions in everything from finance to manufacturing are following a gradually increasing presence in the area for the past few years. In 2016, the company invested $127 million in its casting plant in Bedford and planned to pump an additional $1 billion into the Fort Wayne area over the next few years to double the size of its operation. The expansion of GM’s operations has led to increased business for ...

    • Indy Firm Taps Appirio Exec as CEO

      An Indianapolis-based design and innovation consulting firm has named a new chief executive officer. Studio Science says Steve Pruden, who most recently served as senior vice president of human resources with Indy tech company Appirio, will lead the company.

    • Rose-Hulman Adds New Major

      Rose-Hulman Institute of Technology students now have another option when choosing a major. The Institute has added a engineering design major which is expected to offer a multidisciplinary experience. Students are enrolled to start the new program in the 2018-2019 school year. 

    • (Image Courtesy: Lilly Oncology)

      Lilly Closes on Mega Acquisition

      Indianapolis-based Eli Lilly and Co. (NYSE: LLY) has completed its acquisition of ARMO BioSciences Inc. of California. The deal, which was valued at approximately $1.6 billion when first announced last month, boosts Lilly's immuno-oncology pipeline. Lilly offered $50 per share of ARMO stock for the company. ARMO's portfolio includes...